ruthenium has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergamo, A; Cemazar, M; Hudej, R; Keppler, BK; Martincic, A; Miklavcic, D; Sava, G; Scancar, J; Sersa, G; Todorovic, V; Turel, I | 1 |
Benosman, S; Bischoff, P; Boos, A; Fricker, B; Gaiddon, C; Gross, I; Harlepp, S; Hébraud, P; Jenny, M; Leyva, ML; Loeffler, JP; Meng, X; Pfeffer, M; Sirlin, C; Wlosik, P | 1 |
Alessio, E; Bergamo, A; Cocchietto, M; Gava, B; Iengo, E; Sava, G; Serli, B; Stocco, G | 1 |
3 other study(ies) available for ruthenium and B16 Melanoma
Article | Year |
---|---|
Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Membrane; Electrochemotherapy; Electroporation; Fibrosarcoma; In Vitro Techniques; Melanoma, Experimental; Mice; Organometallic Compounds; Ruthenium | 2014 |
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP.
Topics: Animals; Brain Neoplasms; Cell Division; Cisplatin; Endoplasmic Reticulum; Flow Cytometry; Glioblastoma; Humans; Luciferases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA; Ruthenium; Transcription Factor CHOP | 2009 |
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines.
Topics: Animals; Blotting, Western; Cell Cycle; Cell Division; Cell Survival; DNA, Neoplasm; Flow Cytometry; Humans; KB Cells; Melanoma, Experimental; Mice; Rats; Ruthenium; Spectrophotometry, Atomic; Tumor Cells, Cultured | 2003 |